Breast Conservation After Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer

This phase 3 randomized clinical trial assesses the role of neoadjuvant systemic therapy in conversion from ineligibility to eligibility for breast-conserving therapy and to assess the association of response to therapy, germline BRCA status, and region of treatment with surgical choice in women with triple-negative breast cancer.
Source: JAMA Surgery - Category: Sports Medicine Source Type: research